This Article Full Text Full Text (PDF) Other Versions of this Article: AAC.00847-06v1 50/12/4077    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yamamoto, T. Articles by Tanaka, M. Search for Related Content PubMed PubMed Citation Articles by Yamamoto, T. Articles by Tanaka, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2006, p. 4077-4086, Vol. 50, No. 12
0066-4804/06/$08.00+0     doi:10.1128/AAC.00847-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Molecular Characteristics and In Vitro Susceptibility to Antimicrobial Agents, Including the Des-Fluoro(6) Quinolone DX-619, of Panton-Valentine Leucocidin-Positive Methicillin-Resistant Staphylococcus aureus Isolates from the Community and Hospitals

Division of Bacteriology, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata,¹ Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan²

Received 12 July 2006/ Returned for modification 17 August 2006/ Accepted 4 October 2006

Highly virulent, community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strains with Panton-Valentine leucocidin (PVL) genes have been found increasingly worldwide. Among a total of 2,101 MRSA strains isolated from patients in hospitals in Japan, two were positive for PVL genes. One strain was identified as a community-acquired MRSA strain with genotype sequence type 30 (ST30) and spa (staphylococcal protein A gene) type 19 from Japan and was resistant only to ß-lactam antimicrobial agents. The other strain was closely related to PVL⁺ multidrug-resistant, hospital-acquired MRSA strains (ST30, spa type 43) derived from nosocomial outbreaks in the 1980s to 1990s in Japan but with a divergent sequence type, ST765 (a single-locus variant of ST30). Twenty-two PVL⁺ MRSA strains, including those from Japan and those from other countries with various sequence types (ST1, ST8, ST30, ST59, and ST80) and genotypes, were examined for susceptibility to 31 antimicrobial agents. Among the agents, DX-619, a des-fluoro(6) quinolone, showed the greatest activity, followed by rifampin and sitafloxacin, a fluoroquinolone. The data suggest that DX-619 exhibits a superior activity against PVL⁺ MRSA strains with various virulence genetic traits from the community as well as from hospitals.

Published ahead of print on 16 October 2006.